g1 semaglutide Drugmaker Eli Lilly announced that the FDA approved its daily GLP-1 pill, which will be marketed under the name Foundayo, to treat obesity. ABC News' Youri Benadjaoud reports. , Semaglutide Shows Major Promise for

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context on your GLP-1 receptor sensitivity and appetite-regulation pathway predispositions, which can inform timing conversations with your provider

Hansen, T

TSA Rules for Ice Packs and Gel Packs TSA's public guidance distinguishes medically necessary liquids and cooling accessories from ordinary travel liquids

Treatment length varies based on individual goals, response, and long-term weight management needs

Effects of resveratrol on VEGF & HIF1 genes expression in granulosa cells in the angiogenesis pathway and laboratory parameters of polycystic ovary syndrome: a triple-blind randomized clinical trial

The uncertainty about what youll actually experience can be more stressful than helpful